RT Generic
T1 The utility of biomarkers in traumatic brain injury clinical management.
A1 Rodriguez-Rodriguez, Ana
A1 Egea-Guerrero, Juan Jose
K1 Traumatic brain injury
K1 Biomarkers
K1 Neuron-specific enolase
K1 S100B protein
K1 Prognosis
K1 Extracranial injury
AB We read the article by Thelin et al. entitled “Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity” [1] with great interest. The authors conclude that while S100B and neuron-specific enolase (NSE) are both biomarkers for long-term outcome, S100B is a more accurate predictor.
PB BioMed Central Ltd.
YR 2016
FD 2016-11-18
LK http://hdl.handle.net/10668/10612
UL http://hdl.handle.net/10668/10612
LA en
NO Rodríguez-Rodríguez A, Egea-Guerrero JJ. The utility of biomarkers in traumatic brain injury clinical management. Crit Care. 2016 Nov 18;20(1):376.
DS RISalud
RD Sep 18, 2025